Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Xelpros in Open Angle Glaucoma or Ocular Hypertension
NCT00945958Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Nov 2010
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of latanoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Sun Pharma. Started Nov 2010; status: completed.
02
Drugs
latanoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00945958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945958.